The GAP Foundation commissioned a survey of 2,056 individuals age 18 and older to learn more about Americans’ perception of Alzheimer’s and their willingness to participate in trials.
The survey found while almost 60 percent of Americans said they are willing or would consider participating in a clinical trial for Alzheimer’s disease, less than 10 percent are actually doing so.
These low rates of participation suggest that Americans want to help but don’t have the tools and information needed to do so.
More articles on infection control and clinical quality:
18 overdose deaths cited in the license suspension of Seattle Pain Centers’ director
Many elderly patients receive, use medications inappropriately
Providers don’t understand CT scan cancer risk, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
